Does milk intake promote prostate cancer initiation or progression via effects on insulin-like growth factors (IGFs)? A systematic review and meta-analysis
Open Access
- 30 March 2017
- journal article
- review article
- Published by Springer Nature in Cancer Causes & Control
- Vol. 28 (6) , 497-528
Abstract
Purpose To establish whether the association between milk intake and prostate cancer operates via the insulin-like growth factor (IGF) pathway (including IGF-I, IGF-II, IGFBP-1, IGFBP-2, and IGFBP-3). Methods Systematic review, collating data from all relevant studies examining associations of milk with IGF, and those examining associations of IGF with prostate cancer risk and progression. Data were extracted from experimental and observational studies conducted in either humans or animals, and analyzed using meta-analysis where possible, with summary data presented otherwise. Results One hundred and seventy-two studies met the inclusion criteria: 31 examining the milk–IGF relationship; 132 examining the IGF–prostate cancer relationship in humans; and 10 animal studies examining the IGF–prostate cancer relationship. There was moderate evidence that circulating IGF-I and IGFBP-3 increase with milk (and dairy protein) intake (an estimated standardized effect size of 0.10 SD increase in IGF-I and 0.05 SD in IGFBP-3 per 1 SD increase in milk intake). There was moderate evidence that prostate cancer risk increased with IGF-I (Random effects meta-analysis OR per SD increase in IGF-I 1.09; 95% CI 1.03, 1.16; n = 51 studies) and decreased with IGFBP-3 (OR 0.90; 0.83, 0.98; n = 39 studies), but not with other growth factors. The IGFBP-3 -202A/C single nucleotide polymorphism was positively associated with prostate cancer (pooled OR for A/C vs. AA = 1.22; 95% CI 0.84, 1.79; OR for C/C vs. AA = 1.51; 1.03, 2.21, n = 8 studies). No strong associations were observed for IGF-II, IGFBP-1 or IGFBP-2 with either milk intake or prostate cancer risk. There was little consistency within the data extracted from the small number of animal studies. There was additional evidence to suggest that the suppression of IGF-II can reduce tumor size, and contradictory evidence with regards to the effect of IGFBP-3 suppression on tumor progression. Conclusion IGF-I is a potential mechanism underlying the observed associations between milk intake and prostate cancer risk.Keywords
Funding Information
- World Cancer Research Fund (RFA 2012/620)
- Wellcome (102432/Z/13/Z)
- Medical Research Council (MC_UU_12013/1, MC_UU_12013/2)
- Cancer Research UK (C18281/A19169)
- National Institute for Health and Care Research
This publication has 192 references indexed in Scilit:
- Relaxed imprinting of IGF2 in peripheral blood cells of patients with a history of prostate cancerEndocrine Connections, 2012
- Expression of the IGF Axis Is Decreased in Local Prostate Cancer but Enhanced after Benign Prostate Epithelial Differentiation and TGF-β TreatmentThe American Journal of Pathology, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Plasma insulin‐like growth factor 1 is positively associated with low‐grade prostate cancer in the Health Professionals Follow‐up Study 1993–2004International Journal of Cancer, 2010
- Identification of a Novel Cell Death Receptor Mediating IGFBP-3-induced Anti-tumor Effects in Breast and Prostate CancerJournal of Biological Chemistry, 2010
- Androgens, growth factors, and risk of prostate cancer: The Multiethnic CohortThe Prostate, 2010
- Circulating insulin‐like growth factor peptides and prostate cancer risk: A systematic review and meta‐analysisInternational Journal of Cancer, 2009
- Genetic polymorphisms in CYP17, CYP3A4, CYP19A1, SRD5A2, IGF‐1, and IGFBP‐3 and prostate cancer risk in African‐American men: The Flint Men's Health StudyThe Prostate, 2007
- In silico mining identifies IGFBP3 as a novel target of methylation in prostate cancerBritish Journal of Cancer, 2007
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002